USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SEA RUN HOLDINGS, INC.
Address:
SEA RUN HOLDINGS, INC.
76 PINE ST
FREEPORT, ME 04032
Phone:
(207) 865-9655
URL:
N/A
EIN:
10449243
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $384,175.00 5
SBIR Phase II $1,893,351.00 4
STTR Phase I $0.00 1
STTR Phase II $500,000.00 1

Award List:

FEASIBILITY OF USING LANDLOCKED ATLANTIC SALMON (SALMO SALAR) FOR MARINE CULTURE.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$39,000.00
Agency:
NSF
Principal Investigator:
Evelyn S Sawyer Phd , President
Abstract:
N/a

FEASIBILITY OF USING LANDLOCKED ATLANTIC SALMON (SALMO SALAR) FOR MARINE CULTURE.

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$179,000.00
Agency:
NSF
Principal Investigator:
Evelyn S Sawyer Phd , President
Abstract:
A major problem in marine culture of atlantic salmon (salmo salar) in the north-eastern united states is the lackof eggs and smolts. diadromous (sea-run) atlantic salmon eggs are scarce and needed for restoration purposes. also, young sea-run salmon are difficult to rear through the pre-smolt stage.… More

FEASIBILITY OF HADDOCK (MELANOGRAMMUS AEGLEFINUS) CULTURE

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$47,727.00
Agency:
NSF
Principal Investigator:
Dr Evelyn S Sawyer
Abstract:
N/a

FEASIBILITY OF HADDOCK (MELANOGRAMMUS AEGLEFINUS) CULTURE

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$221,120.00
Agency:
NSF
Principal Investigator:
Dr Evelyn S Sawyer
Abstract:
A severe decline in landings of haddock (melanogrammus aeglefinus) in the northeastern u.s. has resulted in prices similar to those of salmon and market reliance on imports. this creates an opportunity for haddock culture in maine utilizing the facilities already in place for salmon aquaculture.… More

CLOTTING FACTORS FROM FISH BLOOD FOR FIBRIN SEALANTS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$97,788.00
Agency:
HHS
Principal Investigator:
Sawyer, evelyn s
Abstract:
The overall objective of this project is to develop a medical fibrin sealant from fish plasma. Commercial aquaculture rears millions of large salmonids, and the plasma from these fish offers an unexplored and innovative source of highly conserved clotting factors. A major advantage is safety from… More

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase II
Award Amount:
$738,056.00
Agency:
HHS
Principal Investigator:
Sawyer evelyn s
Abstract:
N/a

Salmon clotting proteins for human bandages

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,900.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Evelyn S. Sawyer, Director of Research
Abstract:
Not Available "Fibrin bandages have shown considerable promise in controlling majorblood loss. However, two significant problems are cost, and thepossibility of infectious agents.Our overall objective is to solve both problems with the use offibrinogen and thrombin from salmon plasma. Phase I aims… More

Salmon clotting proteins for human bandages

Award Year / Program / Phase:
2003 / STTR / Phase II
Award Amount:
$500,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Evelyn F. Sawyer, Director of Research
Research Institution:
UNIV. OF PENNSYLVANIA
RI Contact:
Andrew Rudczynski, Ph.D.
Abstract:
Fibrin bandages have shown considerable promise in controlling traumatic bleeding. However, two significant problems are cost, and the possibility of infectious agents.Our overall objective is to solve both problems with the use of fibrinogen and thrombin from salmon plasma. Phase II aim are to 1.… More

Salmon fibrin gels for CNS surgical applications

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$99,760.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our objective is to develop a new biomaterial, a salmon fibrin gel, that will bridge injured CNS tissue, support and promote axonal sprouting and growth, and deliver neurotrophic factors and cells. Aim #1 is to determine the factors, biochemical and… More

Salmon fibrin gels for surgical applications

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$755,175.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our objective is to develop a new biomaterial, a salmon-derived fibrin gel, which will bridge injured CMS tissue, support and promote axonal sprouting and growth, and deliver neurotrophic factors and cells. In Aim #1 we will test the efficacy of salmon-derived… More